LONDON, Oct. 22 -- The government of the United Kingdom issued the following news:
We wish to inform wholesalers that Dechra Pharmaceuticals PLC has initiated a Class II recall to wholesaler level with immediate effect for the following products:
*
Apovomin 3 mg/ml Solution for Injection for Dogs, Vm50406/4002
*
Ophtocycline 10 mg/g eye ointment for dogs, cats and horses, Vm41821/4043
*
Revozyn RTU 400 mg/ml suspension for injection for cattle, Vm16849/3000 & Vm16849/5000
*
Equipalazone 200 mg/ml Solution for Injection Vm50406/3037 & Vm50406/5042
The reason for the recall is due to an increased risk of microbial contamination in the aseptically manufactured products at the site of the contracted manufacturer, in the period from 01/2024 to 05/2025.
This recall is for following batches:
Product
Batch number
Date of Manufacture
Expiry date
Apovomin 3 mg/ml solution for injection for dogs
24K017
Nov 2024
Oct 2027
Apovomin 3 mg/ml solution for injection for dogs
25B254
Feb 2025
Jan 2028
Ophtocycline 10 mg/g eye ointment for dogs, cats and horses
EB
Jan 2025
Dec 2025
Ophtocycline 10 mg/g eye ointment for dogs, cats and horses
ED
May 2024
Apr 2026
Ophtocycline 10 mg/g eye ointment for dogs, cats and horses
EF
May 2024
Apr 2026
Ophtocycline 10 mg/g eye ointment for dogs, cats and horses
FA
Jan 2025
Dec 2026
Ophtocycline 10 mg/g eye ointment for dogs, cats and horses
FC
May 2025
Apr 2027
Revozyn RTU 400 mg/ml suspension for injection for cattle
24J014
Oct 2024
Sep 2026
Equipalazone 200 mg/ml Solution for Injection
151300
April 2024
Mar 2027
Equipalazone 200 mg/ml Solution for Injection
152435
April 2024
Mar 2027
Dechra Pharmaceuticals PLC is contacting wholesalers to examine inventory immediately and quarantine products, subject to this recall.
For further information regarding the recall, please contact: quality@dechra.com, or eu.recall@dechra.com
Disclaimer: Curated by HT Syndication.
